Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Efficacy and Safety Study Comparing Pegylated-Interferon and Ribavirin Plus Metformin to Pegylated-Interferon and Ribavirin in the Treatment of naïve Patients With Genotype 1 Chronic HCV Infection and Insulin Resistance

NCT00370617 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.

NCT NCT00370617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00370617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Efficacy and Safety Study Comparing Pegylated-Interferon and Ribavirin Plus Metformin to Pegylated-Interferon and Ribavirin in the Treatment of naïve Patients With Genotype 1 Chronic HCV Infection and Insulin Resistance
Lead sponsor
University of Turin, Italy
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2006
Completion date
January 31, 2009
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c, insulin resistance